We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.97%
AUM
$45.8B
AUM Growth
-$1.67B
Cap. Flow
-$2.56B
Cap. Flow %
-5.59%
Top 10 Hldgs %
6.8%
Holding
1,994
New
177
Increased
787
Reduced
718
Closed
189

Top Sells

Rank Stock Value
1
VFC icon
VF Corp
VFC
+$164M
2
ODFL icon
Old Dominion Freight Line
ODFL
+$128M
3
A icon
Agilent Technologies
A
+$127M
4
AVY icon
Avery Dennison
AVY
+$120M
5
AFL icon
Aflac
AFL
+$106M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Industrials 14.33%
3 Technology 14.05%
4 Consumer Discretionary 11.58%
5 Healthcare 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWF icon
1726
iShares Russell 1000 Growth ETF
IWF
$127B
$39K ﹤0.01%
1,156
-127,512
-99% -$4.47M
RITM icon
1727
Rithm Capital
RITM
$5.55B
$38K ﹤0.01%
2,322
+928
+67% +$15.8K
ZIXI
1728
DELISTED
Zix Corporation
ZIXI
$38K ﹤0.01%
8,920
DEI icon
1729
Douglas Emmett
DEI
$1.93B
$37K ﹤0.01%
1,005
HR
1730
DELISTED
Healthcare Realty Trust Incorporated
HR
$37K ﹤0.01%
1,340
CBRL icon
1731
Cracker Barrel
CBRL
$1.3B
$36K ﹤0.01%
224
+90
+67% +$14.9K
CYS
1732
DELISTED
CYS Investments Inc.
CYS
$36K ﹤0.01%
5,310
GNMK
1733
DELISTED
GenMark Diagnostics, Inc
GNMK
$35K ﹤0.01%
6,439
ACFC
1734
DELISTED
Atlantic Coast Financial Corporation
ACFC
$34K ﹤0.01%
3,336
-26
-0.8% -$270
DVAX
1735
DELISTED
Dynavax Technologies
DVAX
$31K ﹤0.01%
1,557
NWS icon
1736
News Corp Class B
NWS
$18.3B
$30K ﹤0.01%
1,880
-44
-2% -$737
STML
1737
DELISTED
Stemline Therapeutics, Inc.
STML
$28K ﹤0.01%
1,858
ARWR icon
1738
Arrowhead Research
ARWR
$12.1B
$26K ﹤0.01%
3,599
TGTX icon
1739
TG Therapeutics
TGTX
$7.58B
$26K ﹤0.01%
1,841
-1,215
-40% -$15.5K
ONCE
1740
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$26K ﹤0.01%
394
JBGS
1741
JBG SMITH
JBGS
$707M
$25K ﹤0.01%
744
RIGL icon
1742
Rigel Pharmaceuticals
RIGL
$733M
$25K ﹤0.01%
705
-460
-39% -$18.4K
SGYP
1743
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$25K ﹤0.01%
13,507
VAC icon
1744
Marriott Vacations Worldwide
VAC
$4.28B
$24K ﹤0.01%
183
-271
-60% -$38.3K
RARE icon
1745
Ultragenyx Pharmaceutical
RARE
$2.55B
$23K ﹤0.01%
443
CLLS
1746
Cellectis
CLLS
$271M
$22K ﹤0.01%
683
CSTE icon
1747
Caesarstone
CSTE
$76.1M
$21K ﹤0.01%
1,087
RETA
1748
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$21K ﹤0.01%
1,000
-23,670
-96% -$609K
ESPR
1749
DELISTED
Esperion Therapeutics
ESPR
$20K ﹤0.01%
282
JBTM
1750
JBT Marel
JBTM
$6.33B
$20K ﹤0.01%
178
-2,575
-94% -$295K

Similar funds

Victory Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Victory Capital Management held 1,994 positions worth $45.8B, down 3.5% from $47.5B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Victory Capital Management withdrew a net $2.56B in Q1 2018, closing 189 positions and reducing 718 holdings. Its most notable exit was Wells Fargo 7.5% Non Cumv Perp Conv, an estimated $64.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

Against the trend, Victory Capital Management opened a new position in Steris worth $114M.

  • Victory Capital Management's largest Q1 2018 buy was Steris: 1,225,800 shares worth $114M.
  • Victory Capital Management added most to Kroger in Q1 2018, an estimated $227M increase.
  • Victory Capital Management's biggest Q1 2018 reduction was VF Corp, cutting an estimated $164M.
  • Victory Capital Management fully exited Wells Fargo 7.5% Non Cumv Perp Conv in Q1 2018, selling an estimated $64.4M.
  • Victory Capital Management's ten largest holdings make up 6.8% of its $45.8B portfolio in Q1 2018.
  • Victory Capital Management opened 177 new positions and closed 189 in Q1 2018.
  • Victory Capital Management's portfolio value fell 3.5% quarter-over-quarter to $45.8B.

Based on Victory Capital Management's 13F filing for Q1 2018, filed 4 May 2018.